Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 337 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is K  [Clear All Filters]
2002
Kirk BW, Feinsod M, Favis R, Kliman RM, Barany F.  2002.  Single nucleotide polymorphism seeking long term association with complex disease.. Nucleic Acids Res. 30(15):3295-311.
2001
Kojic M, Thompson CW, Holloman WK.  2001.  Disruptions of the Ustilago maydis REC2 gene identify a protein domain important in directing recombinational repair of DNA.. Mol Microbiol. 40(6):1415-26.
Kaps I, Ehrt S, Seeber S, Schnappinger D, Martin C, Riley LW, Niederweis M.  2001.  Energy transfer between fluorescent proteins using a co-expression system in Mycobacterium smegmatis.. Gene. 278(1-2):115-24.
Kadekoppala M, Cheresh P, Catron D, Ji DD, Deitsch K, Wellems TE, Seifert HS, Haldar K.  2001.  Rapid recombination among transfected plasmids, chimeric episome formation and trans gene expression in Plasmodium falciparum.. Mol Biochem Parasitol. 112(2):211-8.
Chitale S, Ehrt S, Kawamura I, Fujimura T, Shimono N, Anand N, Lu S, Cohen-Gould L, Riley LW.  2001.  Recombinant Mycobacterium tuberculosis protein associated with mammalian cell entry.. Cell Microbiol. 3(4):247-54.
Byrnes AA, Ma X, Cuomo P, Park K, Wahl L, Wolf SF, Zhou H, Trinchieri G, Karp CL.  2001.  Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity.. Eur J Immunol. 31(7):2026-34.
2000
Kojic M, Holloman WK.  2000.  Shuttle vectors for genetic manipulations in Ustilago maydis.. Can J Microbiol. 46(4):333-8.
1999
Niederweis M, Ehrt S, Heinz C, Klöcker U, Karosi S, Swiderek KM, Riley LW, Benz R.  1999.  Cloning of the mspA gene encoding a porin from Mycobacterium smegmatis.. Mol Microbiol. 33(5):933-45.
Niederweis M, Ehrt S, Heinz C, Klöcker U, Karosi S, Swiderek KM, Riley LW, Benz R.  1999.  Cloning of the mspA gene encoding a porin from Mycobacterium smegmatis.. Mol Microbiol. 33(5):933-45.
Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J et al..  1999.  Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.. Am J Respir Cell Mol Biol. 20(3):361-70.
Na SY, Kang BY, Chung SW, Han SJ, Ma X, Trinchieri G, Im SY, Lee JW, Kim TS.  1999.  Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB.. J Biol Chem. 274(12):7674-80.
Na SY, Kang BY, Chung SW, Han SJ, Ma X, Trinchieri G, Im SY, Lee JW, Kim TS.  1999.  Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB.. J Biol Chem. 274(12):7674-80.
Cole-Strauss A, Gamper H, Holloman WK, Muñoz M, Cheng N, Kmiec EB.  1999.  Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract.. Nucleic Acids Res. 27(5):1323-30.
1998
Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchieri G.  1998.  Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance.. Eur J Immunol. 28(10):3128-36.
Kapitskaya MZ, Dittmer NT, Deitsch KW, Cho WL, Taylor DG, Leff T, Raikhel AS.  1998.  Three isoforms of a hepatocyte nuclear factor-4 transcription factor with tissue- and stage-specific expression in the adult mosquito.. J Biol Chem. 273(45):29801-10.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
1997
Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E et al..  1997.  Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.. Hum Gene Ther. 8(1):99-109.
Abrahamsen K, Kong HL, Mastrangeli A, Brough D, Lizonova A, Crystal RG, Falck-Pedersen E.  1997.  Construction of an adenovirus type 7a E1A- vector.. J Virol. 71(11):8946-51.
Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Trinchieri G, Karp CL.  1997.  Inhibition of human interleukin-12 production by pentoxifylline.. Immunology. 91(2):197-203.
Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Flockhart DA, Trinchieri G, Karp CL.  1997.  Inhibition of IL-12 production by thalidomide.. J Immunol. 159(10):5157-61.
Ferguson DO, Rice MC, Rendi MH, Kotani H, Kmiec EB, Holloman WK.  1997.  Interaction between Ustilago maydis REC2 and RAD51 genes in DNA repair and mitotic recombination.. Genetics. 145(2):243-51.
Ferguson DO, Rice MC, Rendi MH, Kotani H, Kmiec EB, Holloman WK.  1997.  Interaction between Ustilago maydis REC2 and RAD51 genes in DNA repair and mitotic recombination.. Genetics. 145(2):243-51.
1996
Gall J, Kass-Eisler A, Leinwand L, Falck-Pedersen E.  1996.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.. J Virol. 70(4):2116-23.
Kass-Eisler A, Leinwand L, Gall J, Bloom B, Falck-Pedersen E.  1996.  Circumventing the immune response to adenovirus-mediated gene therapy.. Gene Ther. 3(2):154-62.